The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients
Year: 
2018
Journal: 
ACTA OPHTHALMOLOGICA
Vaes, AW; Spruit, MA; Theunis, J; Goswami, N; Vanfleteren, LE; Franssen, FME; Wouters, EFM; De Boever, P
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Year: 
2018
Journal: 
JOURNAL OF EXTRACELLULAR VESICLES
Thery, C; Witwer, KW; Aikawa, E; Alcaraz, MJ; Anderson, JD; Andriantsitohaina, R; Antoniou, A; Arab, T; Archer, F; Atkin-Smith, GK; Ayre, DC; Bach, JM; Bachurski, D; Baharvand, H; Balaj, L; Baldacchino, S; Bauer, NN; Baxter, AA; Bebawy, M; Beckham, C; Zav
Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats
Year: 
2018
Journal: 
PLOS ONE
Everson, F; Genis, A; Ogundipe, T; De Boever, P; Goswami, N; Lochner, A; Blackhurst, D; Strijdom, H
Multi-night continuous nocturnal oxygen saturation measurements in patients with COPD
Year: 
2018
Journal: 
EUROPEAN RESPIRATORY JOURNAL
Buekers, J; Aerts, JM; Theunis, J; Vaes, A; Wouters, E; Spruit, M; De Boever, P

Pages